Inventor profile of:

Andreas Kjær

City:

Frederiksberg

Country:

Denmark

Published Applications:

28

Last publication date:

2026-04-23

Top Assignees for applications by Andreas Kjær

The entities that hold a legal rights for patent applications filed by inventor Kjær Andreas:

Recent patent applications by Kjær Andreas

Andreas Kjær from Frederiksberg, DK has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-23
US20260108638A1
Human necessities

68GA- AND 64CU -NODAGA-E[C(RGDYK)]2 FOR USE AS PET TRACERS IN THE IMAGING OF ANGIOGENESIS IN HUMANS

#2 | 2024-06-06
US20240182382A1
Chemistry; metallurgy

ALIPHATIC 18F-RADIOLABELING OF A TETRAZINE PRECURSOR

#3 | 2024-01-11
US20240009331A1
Human necessities

UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR TARGETED RADIOLABELED PEPTIDE CONJUGATES

#4 | 2023-05-11
US20230146930A1
Human necessities

177-LU LABELED ACTIVE SITE INHIBITED FACTOR VII

#5 | 2023-04-20
US20230117827A1
Human necessities

COMPOSITION COMPRISING A FLUOROPHORE LABELLED UPAR-TARGETING PEPTIDE CONJUGATE

#6 | 2022-12-22
US20220401585A1
Human necessities

A UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-TARGETING PEPTIDE

#7 | 2022-08-18
US20220257799A1
Human necessities

A RECEPTOR-TARGETING CONJUGATE WITH AN EFFECTIVE PHARMACOKINETIC PROFILE

#8 | 2022-06-30
US20220202966A1
Human necessities

POSITRON EMITTING RADIONUCLIDE LABELED PEPTIDES FOR HUMAN UPAR PET IMAGING

#9 | 2022-01-13
US20220008569A1
Human necessities

PET TRACER FOR IMAGING OF NEUROENDOCRINE TUMORS

#10 | 2021-08-05
US20210236666A1
Human necessities

177-Lu LABELED PEPTIDE FOR SITE-SPECIFIC uPAR-TARGETING

#11 | 2021-05-13
US20210138090A1
Human necessities

uPAR targeting peptide for use in peroperative optical imaging of invasive cancer

#12 | 2020-09-10
US20200282084A1
Human necessities

68GA- AND 64CU -NODAGA-E[C(RGDYK)]2 FOR USE AS PET TRACERS IN THE IMAGING OF ANGIOGENESIS IN HUMANS

#13 | 2020-08-27
US20200268914A1
Human necessities

Positron emitting radionuclide labeled peptides for human uPAR PET imaging

#14 | 2019-11-28
US20190358351A1
Human necessities

177-LU LABELED ACTIVE SITE INHIBITED FACTOR VII

#15 | 2019-10-24
US20190321497A1
Human necessities

PET tracer for imaging of neuroendocrine tumors

#16 | 2019-05-02
US20190125903A1
Human necessities

UPAR TARGETING PEPTIDE FOR USE IN PEROPERATIVE OPTICAL IMAGING OF INVASIVE CANCER

#17 | 2019-03-21
US20190083664A1
Human necessities

PET tracer for imaging of neuroendocrine tumors

#18 | 2019-01-17
US20190015532A1
Human necessities

QUANTITATIVE PET IMAGING OF TISSUE FACTOR EXPRESSION USING 18F-LABLED ACTIVE SITE INHIBITED FACTOR VII

#19 | 2018-07-12
US20180193495A1
Human necessities

POSITRON EMITTING RADIONUCLIDE LABELED PEPTIDES FOR HUMAN UPAR PET IMAGING

#20 | 2017-10-26
US20170304468A1
Human necessities

uPAR targeting peptide for use in peroperative optical imaging of invasive cancer

#21 | 2016-09-15
US20160263260A1
Human necessities

Positron emitting radionuclide labeled peptides for human uPAR PET imaging

#22 | 2016-06-09
US20160158392A1
Human necessities

Entrapment of Radionuclides in Nanoparticle Compositions

#23 | 2015-07-23
US20150202336A1
Human necessities

Loading Technique for Preparing Radionuclide Containing Nanoparticles

#24 | 2015-05-14
US20150132219A1
Human necessities

177-Lu labeled peptide for site-specific uPAR-targeting

#25 | 2014-11-20
US20140341807A1
Human necessities

Pet tracer for imaging of neuroendocrine tumors

#26 | 2013-09-26
US20130251630A1
Human necessities

Entrapment of radionuclides in nanoparticle compositions

#27 | 2012-08-23
US20120213698A1
Human necessities

Loading technique for preparing radionuclide containing nanoparticles

#28 | 2006-01-26
US20060018831A1
Human necessities

TF binding agent and use thereof

InventorID:

454948